Keywords: nicox, ncx, moves, into, preclinical, development, french

NicOx' NCX 6560 moves into preclinical development

Article | 11 September 2006

Print This

French drugmaker NicOx SA says it plans to move its drug candidate NCX 6560 into preclinical development as a statin with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in